Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Saved in:
Bibliographic Details
Title: Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Authors: Ruff SM; Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center/James Comprehensive Cancer Center, Columbus, OH, United States., Kasumova G; Division of Surgical Oncology, Department of Surgery, Central Maine Medical Center, Lewiston, ME, United States., Palavalli M; Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center/James Comprehensive Cancer Center, Columbus, OH, United States., Eng OS; Department of Surgical Oncology, University of California Irvine Medical Center, Irvine, CA, United States., Lambert L; Department of Surgical Oncology, University of Utah, Salt Lake City, UT, United States., Clarke C; Department of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI, United States., Patel S; Department of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States., Veerapong J; Department of Surgical Oncology, University of California San Diego, San Diego, CA, United States., Fournier K; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, United States., Abbott D; Department of Surgical Oncology, University of Wisconsin Medical Center, Madison, WI, United States., Staley C; Department of Surgical Oncology, Emory University Hospital, Atlanta, GA, United States., Grotz T; Department of Surgery, Mayo Clinic, Rochester, MN, United States., Johnston F; Department of Surgical Oncology, The Johns Hopkins University, Baltimore, MD, United States., Raoof M; Department of Surgical Oncology, City of Hope Cancer Center, Duarte, CA, United States., Dineen S; Department of Surgical Oncology, Moffitt Cancer Center, Tampa, FL, United States., Cloyd JM; Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center/James Comprehensive Cancer Center, Columbus, OH, United States., Kim AC; Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Source: Frontiers in oncology [Front Oncol] 2025 Jan 09; Vol. 14, pp. 1456920. Date of Electronic Publication: 2025 Jan 09 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2024.1456920